TAILORING DIAGNOSIS AND TREATMENT OF DISEASE TO THE PATIENT GENETICS  - WHO WILL PAY?

"CONCLUSION. . . .
We have provided this information for CMS’s use in setting Medicare coverage and payment policies for genetic tests. Because State Medicaid programs and private health insurance plans closely monitor Medicare’s coverage and reimbursement decisions, CMS’s formulation of reimbursement rates for genetic tests may be useful to them. As one official from a State Medicaid program remarked, “Additional guidance from CMS on genetic testing would be very helpful. We have struggled with payment of such tests for the last couple of years ...."